Effects of Bifidobacterium Lactis BS01 and Lactobacillus Acidophilus LA02 on cognitive functioning in healthy women.

A growing body of research studies the relationship between probiotic bacteria in the gut and the host organism, including the impact on cognitive functioning. Data from human studies are scarce; however, recent studies point toward the beneficial role of probiotics for cognitive functioning. One of the mechanisms involved in this relationship is the probiotic's ability to influence inflammation and immune response. The aim of this initial study was to investigate the effects of probiotic supplementation with Bifidobacterium Lactis BS01 and Lactobacillus Acidophilus LA02 on cognitive functioning in healthy, young adult females. A total of 53 participants aged 19-31 were enrolled, and 38 completed the trial. A 6-week probiotic or placebo treatment was conducted. Five measures of cognitive functioning were applied pre- and post-treatment. Both groups showed general improvement at the second assessment. Contrary to our hypothesis, the placebo group improved slightly, but significantly, in four out of five measures of cognitive functioning, with the exception of the Wisconsin Card Sorting Test (WCST). The supplementation group improved significantly in two measures of the WCST, compared to the placebo group. Similar results have been previously reported. Probiotic supplementation, while not harmful, might not be beneficial for cognition in the healthy population, or at least not universally.

Decreased preparatory activation and inattention to cues suggest lower activation of proactive cognitive control among high procrastinating students.

Procrastination is a voluntary delay in completing an important task while being aware that this behavior may lead to negative outcomes. It has been shown that an increased tendency to procrastinate is associated with deficits in some aspects of cognitive control. However, none of the previous studies investigated these dysfunctions through the lenses of the Dual Mechanisms Framework, which differentiates proactive and reactive modes of control. The present study was designed to fill this gap, using behavioral and neurophysiological assessment during the completion of the AX-Continuous Performance Task (AX-CPT) by high (HP) and low (LP) procrastinating students (N = 139). Behavioral results indicated that HP (vs. LP) were characterized by increased attentional fluctuations (higher reaction time variability) and reduction in some indices of proactive cognitive control (lower d'-context and A-cue bias, but similar PBIs). Furthermore, the neurophysiological data showed that HP, compared with LP, allocated less attentional resources (lower P3b) to cues that help to predict the correct responses to upcoming probes. They also responded with reduced preparatory activity (smaller CNV) after cues presentation. The two groups did not differ in neural responses linked to conflict detection and inhibition (similar N2 and P3a). Obtained findings indicate that HP might present deficits in some cognitive functions that are essential for effective proactive control engagement, along with preserved levels of reactive cognitive control. In the present paper, we discuss the potential neural and cognitive mechanisms responsible for the observed effects.

Acceptance, coping strategies and health behaviors in bipolar disorder patients taking and not taking lithium carbonate.

BACKGROUND: The variety of dysfunctions in bipolar disorder (BD) affects patients' perceptions of the diagnosis, acceptance, and illness. Treatment of people with BD includes pharmacotherapy and psychotherapy. Maintaining long-term therapy is difficult, related to the patients' overall approach to health. The aim was to assess health attitudes in people with BD treated with different mood stabilizers. PARTICIPANTS AND PROCEDURE: The study group included 40 patients diagnosed with bipolar disorder. Participants were divided into two groups depending on the medication taken: a group taking lithium (n = 20) and a group not taking lithium, treated with other drugs (n = 20). The respondents were measured with psychological tests - Addenbrooke's Cognitive Examination, Illness Acceptance Scale, Health Behavior Inventory, and Coping Inventory in Crisis Situations. RESULTS: 85% of the respondents stopped taking medication at least once without the doctor's knowledge. People taking lithium had a significantly lower acceptance of the disease (t = -2.27, p = .015). The study groups did not differ in terms of coping with stress and health behaviors. The correlation analysis indicated that the acceptance of disease and health behaviors are significantly associated with selected coping strategies. CONCLUSIONS: Attitudes towards health, understood as acceptance of the disease, coping with stress, and health behaviors are average. It is advisable to develop an optimal approach to activities connected with the daily health maintenance of the patients in order to better cope with the disease and its symptoms.

The influence of Li+ ions on pepsin and trypsin activity in vitro.

BACKGROUND: The paper presents a study on the influence of different lithium carbonate and lithium citrate concentration on proteolytic enzymes, namely pepsin and trypsin, in vitro. Lithium can directly affect enzyme activity. Its influence on many bodily functions in both ill and healthy people has been proven. METHODS: To assess the influence of Li+ ions concentration and the substrate/enzyme ratio on pepsin and trypsin activity in vitro, 60 factorial experiments were conducted (each repeated 30 times). MAIN FINDINGS: For both enzymes, statistically significant changes in their activity under the influence of lihium carbonate and lithium citrate were observed. The biggest increase in enzyme activity reached even 198.6 % and the largest decrease in enzyme activity reached about 50 %. CONCLUSIONS: The study shows that both organic and inorganic forms of lithium salts cause changes in the activity of digestive enzymes. Different concentrations of lithium carbonate and lithium citrate stimulate or inhibit the activity of trypsin and pepsin.

Does probiotic supplementation aid weight loss? A randomized, single-blind, placebo-controlled study with Bifidobacterium lactis BS01 and Lactobacillus acidophilus LA02 supplementation.

PURPOSE: Probiotic supplements are gaining popularity worldwide. This trend is especially present in females, and a common motivation for consumption is weight loss, no matter the BMI. The aim of this study was to investigate the effects of probiotic supplementation on weight loss in healthy, young adult females and to put claims made by manufacturers of such products to the test. METHODS: The study utilizes a randomized, single-blind, placebo-control design. 53 females aged 19-33 were enrolled, and 38 completed the trial. A 6 week supplementation with Bifidobacterium lactis BS01 and Lactobacillus acidophilus LA02 or placebo was conducted. Anthropometric measures (body mass, BMI, body fat percentage, arm skinfold fat, waist circumference, and WHR) were applied pre and post-treatment. RESULTS: No significant changes in anthropometric measures were observed in both supplementation and placebo groups. CONCLUSION: The results of this investigation do not support claims made by probiotic products manufacturers, that they aid weight loss. Our results seem to support an argument that weight loss is mostly associated with food habits and dietary behaviors, not probiotic intake. It is possible that probiotic supplementation may play a facilitating weight loss but has no effect without dietary intervention. Another possible explanation is that due to strain specificity-bacteria strains used in this study are not effective for weight loss. LEVEL OF EVIDENCE: I: randomized controlled trial.